X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-01-16 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $19.65 | -100,000 | 2,373,500 | -4% | -$1,965,000 | ||||||
2023-11-14 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.15 | -1,810 | 2,473,500 | 0% | -$29,224 | ||||||
M | 2023-09-29 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.27 | -104,773 | 2,475,310 | -4% | -$1,704,513 | |||||
M | 2023-09-27 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.11 | -9,357 | 2,580,083 | 0% | -$150,708 | |||||
2023-09-13 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.00 | -400 | 2,589,440 | 0% | -$6,400 | ||||||
M | 2023-09-06 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.03 | -7,140 | 2,589,840 | 0% | -$114,484 | |||||
2023-08-23 | ANTX | Adjuvant Global Health Technology Fund, L.P. | 10% | S - Sale | $16.00 | -400 | 2,596,980 | 0% | -$6,400 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |